| 0 |
Programmed Death Ligand-1 Blocker [EPC] |
7 |
0.0003 |
| 1 |
CTLA-4-directed Blocking Antibody [EPC] |
7 |
0.0001 |
| 2 |
Programmed Death Receptor-1 Blocking Antibody [EPC] |
9 |
0.0001 |
| 3 |
Bile Acid [EPC] |
2 |
0.0001 |
| 4 |
Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] |
3 |
0.0001 |
| 5 |
Vascular Endothelial Growth Factor Inhibitor [EPC] |
8 |
0.0000 |
| 6 |
Kinase Inhibitor [EPC] |
22 |
0.0000 |
| 7 |
Radiographic Contrast Agent [EPC] |
1 |
0.0000 |
| 8 |
Dipeptidyl Peptidase 4 Inhibitor [EPC] |
1 |
0.0000 |
| 9 |
Factor Xa Inhibitor [EPC] |
8 |
0.0000 |
| 10 |
Rifamycin Antibacterial [EPC] |
1 |
0.0000 |
| 11 |
Hepatitis C Virus NS5A Inhibitor [EPC] |
1 |
0.0000 |
| 12 |
Histamine-2 Receptor Antagonist [EPC] |
2 |
0.0000 |
| 13 |
Nucleoside Analog Antiviral [EPC] |
1 |
0.0000 |
| 14 |
Integrin Receptor Antagonist [EPC] |
1 |
0.0000 |
| 15 |
Nitrate Vasodilator [EPC] |
1 |
0.0000 |
| 16 |
Purine Antimetabolite [EPC] |
1 |
0.0000 |
| 17 |
Aminosalicylate [EPC] |
1 |
0.0000 |
| 18 |
Mood Stabilizer [EPC] |
2 |
0.0000 |
| 19 |
Sulfonylurea [EPC] |
1 |
0.0000 |
| 20 |
Platinum-based Drug [EPC] |
2 |
0.0000 |
| 21 |
Nucleoside Metabolic Inhibitor [EPC] |
2 |
0.0000 |
| 22 |
alpha-Adrenergic Blocker [EPC] |
1 |
0.0000 |
| 23 |
Aldosterone Antagonist [EPC] |
1 |
0.0000 |
| 24 |
Dihydropyridine Calcium Channel Blocker [EPC] |
2 |
0.0000 |
| 25 |
RANK Ligand Inhibitor [EPC] |
1 |
0.0000 |
| 26 |
Anti-epileptic Agent [EPC] |
1 |
0.0000 |
| 27 |
Proton Pump Inhibitor [EPC] |
2 |
0.0000 |
| 28 |
Osmotic Laxative [EPC] |
1 |
0.0000 |
| 29 |
beta-Adrenergic Blocker [EPC] |
1 |
0.0000 |
| 30 |
Angiotensin 2 Receptor Blocker [EPC] |
1 |
0.0000 |
| 31 |
Corticosteroid [EPC] |
2 |
0.0000 |
| 32 |
Tumor Necrosis Factor Blocker [EPC] |
1 |
0.0000 |